益气复脉注射液辅助琥珀酸美托洛尔缓释片治疗冠心病并发心力衰竭的效果
|
摘要
目的探究益气复脉注射液联合琥珀酸美托洛美尔缓释片治疗冠心病并发心力衰竭的效果。方法选取我院2016年2月至2017年2月收治的98例冠心病并发心力衰竭患者为研究对象,按随机数字表法将其分成观察组(49例)和常规组(49例)。常规组行琥珀酸美托洛尔缓释片治疗,观察组行益气复脉注射液辅助琥珀酸美托洛尔缓释片治疗。比较两组患者的临床疗效、治疗前、后超声心动图情况、心率及血压。结果观察组的治疗总有效率显著高于常规组,差异具有统计学意义(P<0.05);治疗2周后,两组患者的LVEF均显著升高,LVEDD、心率、收缩压、舒张压均显著降低,且观察组均优于常规组(P<0.05)。结论益气复脉注射液辅助琥珀酸美托洛尔缓释片治疗冠心病心力衰竭患者具有较好的临床效果。
Objective To explore the effect of Yiqi Fumai injection and metoprolol succinate sustained release tablets in coronary heart disease complicated with heart failure. Methods From February 2016 to February 2017, 98 patients with coronary heart disease complicated with heart failure in our hospital were selected and divided into observation group(n=49) and routine group(n=49) by random number table method. The routine group was treated with metoprolol succinate sustained release tablets,and the observation group was treated with Yiqi Fumai injection and metoprolol succinate sustained release tablets. The clinical treatment effects, echocardiogram, heart rates and blood pressure before and after treatment between the two groups were compared. Results After treatment, the total effective rate of treatment in the observation group was significantly higher than that in the routine group(P<0.05). After 2 weeks of treatment, the LVEF of the two groups increased significantly, and the LVEDD, heart rates, systolic blood pressure and diastolic blood pressure decreased significantly, and those in the observation group were better than the routine group(P <0.05). Conclusion Yiqi Fumai injection and metoprolol succinate sustained release tablets in coronary heart disease complicated with heart failure has a good clinical effect.
Objective To explore the effect of Yiqi Fumai injection and metoprolol succinate sustained release tablets in coronary heart disease complicated with heart failure. Methods From February 2016 to February 2017, 98 patients with coronary heart disease complicated with heart failure in our hospital were selected and divided into observation group(n=49) and routine group(n=49) by random number table method. The routine group was treated with metoprolol succinate sustained release tablets,and the observation group was treated with Yiqi Fumai injection and metoprolol succinate sustained release tablets. The clinical treatment effects, echocardiogram, heart rates and blood pressure before and after treatment between the two groups were compared. Results After treatment, the total effective rate of treatment in the observation group was significantly higher than that in the routine group(P<0.05). After 2 weeks of treatment, the LVEF of the two groups increased significantly, and the LVEDD, heart rates, systolic blood pressure and diastolic blood pressure decreased significantly, and those in the observation group were better than the routine group(P <0.05). Conclusion Yiqi Fumai injection and metoprolol succinate sustained release tablets in coronary heart disease complicated with heart failure has a good clinical effect.
引文
[1]赵建伟,刘朔.美托洛尔联合曲美他嗪治疗冠心病心力衰竭的临床分析[J].中国实用医药,2016,11(17):144-145.
[2]梁峰,沈珠军.冠心病合并急性心力衰竭的诊治现状和展望[J].临床内科杂志,2016,33(1):16-20.
[3]谢琴.浅谈老年人发生冠心病心力衰竭的诱因及对其进行护理的方法[J].当代医药论丛,2016,14(7):50-51.
[4]熊向晖,邓旭.八段锦对冠心病慢性心力衰竭患者的疗效观察[J].中国现代医药杂志,2016,18(5):55-56.
[5]张越虹,庄军,安洪亮.曲美他嗪治疗冠心病合并心力衰竭的临床疗效及安全性分析[J].中国医药指南,2016,14(8):55.
[6]苏大为.曲美他嗪联合琥珀酸美托洛尔治疗冠心病心力衰竭患者50例临床观察[J].甘肃科技,2017,33(21):103-104.
[2]梁峰,沈珠军.冠心病合并急性心力衰竭的诊治现状和展望[J].临床内科杂志,2016,33(1):16-20.
[3]谢琴.浅谈老年人发生冠心病心力衰竭的诱因及对其进行护理的方法[J].当代医药论丛,2016,14(7):50-51.
[4]熊向晖,邓旭.八段锦对冠心病慢性心力衰竭患者的疗效观察[J].中国现代医药杂志,2016,18(5):55-56.
[5]张越虹,庄军,安洪亮.曲美他嗪治疗冠心病合并心力衰竭的临床疗效及安全性分析[J].中国医药指南,2016,14(8):55.
[6]苏大为.曲美他嗪联合琥珀酸美托洛尔治疗冠心病心力衰竭患者50例临床观察[J].甘肃科技,2017,33(21):103-104.